SHLD vs XAR: Should Play the Rearmament Boom in 2026
As defense budgets surge in 2026, SHLD and XAR offer two distinct routes to ride the rearmament boom: a global tech t...
If you click a phishing link, act quickly: disconnect, scan devices, change passwords, and report the incident to protect your crypto assets.
17,697 articlesAs defense budgets surge in 2026, SHLD and XAR offer two distinct routes to ride the rearmament boom: a global tech t...
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Insider moves can mislead, but context matters. This article explains why Nick Khan’s 9,589 share sale isn’t a warnin...
Tesla stands out as a founder led tech titan in a sea of transitions. This guide explains why elon musk's tesla remai...
As EV demand rises, Gentherm faces an earnings path shaped by margins, backlog, and product mix. This guide breaks do...
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
A practical, investor-focused look at delcath (dcth) 2025 earnings prospects. We break down the catalysts, risks, and...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Imagine a tech titan quietly owning a defense tech unicorn valued at $1B. This piece breaks down the implications for...
Nvidia has dazzled investors with AI-driven growth, but a hidden threat could derail the rally. This article identifi...
PayPal has fallen sharply from its peak. This guide explains how to evaluate a potential dip buy, weighing risk, fund...
When a top executive sells stock, the market takes notice. This deeper look at Bristow Group's just sold helps you se...